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A B S T R A C T
Background:  To date, it is unclear how treatment of patients with chronic venous disease (CVD) is influenced 
by  national  reimbursement  systems.  In  Belgium,  catheters  or  fibers  used  for  endovenous  thermal  ablation 
(EVTA) are reimbursed only once in a lifetime. The potential impact of the Belgian public health insurance 
reimbursement policy on surgical practice in phlebology needs to be investigated.
Methods: Billing data available from the Belgian National Institute for Health and Disability Insurance 
(NIHDI) were used for analyzing the distribution of specific surgical procedures for treating varicose veins and 
their relative use from 2007 to 2017. The potential influence of age, sex, social status and geographical origin 
of insured patients on surgical practice in Belgium were studied.
Results: The annual intervention rate was 343 per 100,000 insured individuals for 2017 with a slight annual 
increase  over  the  period  2007-2017  (+  0.83% per  year).  Patients with  limited  resources,  benefiting  from  a 
preferential  reimbursement  system,  had  a  significantly  lower  intervention  rate  than  those  having  the  usual 
system (P<0.001). There was a large geographical variation in the use of care, ranging from 172 to 549 per 
100.000 insured in 2017. The number of classic surgical procedures decreased (-6.17% per year) in the period 
2015-2017) while EVTA, newly reimbursed in Belgium since 2012, increased during the same period (+ 3.6% 
per year). This evolution was more pronounced in the north (Flanders) than in the south (Wallonia) of the 
country. Bilateral treatment increased considerably from 2012 and stabilized at 33% of all surgical interventions 
in 2016 and 2017.
Conclusions: Available data of the NIHDI in Belgium highlight remarkable differences in the use of care 
for CVD, depending on social status and geographical origin of insured patients. The introduction of EVTA 
techniques has been adopted more rapidly in the north of the country and has led to an increased percentage of 
bilateral procedures.
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tervention carried out, their geographical distribution over 
the country, their evolution over time and the potential in-
fluence of changes in reimbursement policies. The NIHDI 
has started publishing public standard reports on variations 
in practice since April 2019.13, 14 This material opens up an 
opportunity to medical associations, like the Phlebology 
Working Group of the Belgian Society of Vascular Sur-
gery, to look at their own practice, trying to understand the 
distribution and evolution of phlebological surgical prac-
tice in Belgium over the last 10 years (2007-2017).
The aim of the present study was therefore to better un-
derstand phlebological practice in Belgium by addressing 
several questions. Are Belgian data consistent with inter-
national epidemiological data? What can we learn about 
surgical practice in phlebology in Belgium? Did this prac-
tice evolve in line with international recommendations? 
Is it possible to identify factors influencing the evolution 
of Belgian phlebological practice? Finally, as endovenous 
techniques have been reimbursed in Belgium since the 
end of 2012,10, 11 to what extent has reimbursement policy 
influenced  the  establishment  of  these  techniques  in Bel-
gium?
Materials and methods
Billing  (reimbursement)  codes  of  specific  phlebologi-
cal surgical procedures in Belgium were selected for this 
study.15 Interventions consisting of sclerotherapy only 
were excluded. There are 10 surgical reimbursement codes 
and two codes for reimbursement of equipment (Table I). 
Three codes are certified for phlebectomy invoicing, one 
code for small saphenous vein (SSV) ablation, five codes 
for great saphenous vein (GSV) ablation, one code for bi-
lateral varicose veins ablation and another one for surgical 
ligation of perforating veins. There are no specific codes 
for endovenous techniques available so far. Therefore, to 
calculate the number of thermal ablations performed, we 
additionally queried the billing codes related to reimburse-
ment  of  specific  equipment  used  for  these  endovenous 
techniques. We should also note that the present analysis is 
The prevalence of chronic venous disease (CVD) is high, with a multifactorial etiology.1 The risk factors 
for its occurrence are age and gender, family history and 
pregnancies.2 A sedentary lifestyle and being overweight 
aggravate the symptoms.3 The diagnosis is essentially 
clinical (the ‘C’ of the CEAP classification, Clinical Etio-
logical Anatomical Pathophysiological classification)4 but 
it should be systematically supplemented by a duplex ul-
trasound to clarify the anatomy, etiology and pathophys-
iology, to determine the treatment strategy. The goal of 
treatment is to reduce the venous hypertension that causes 
CVD. The variability of clinical presentations accounts 
for the diverse range of treatments that are offered world-
wide. Apart from a conservative approach by means of 
compression, physical exercise and venotonic medication, 
there are also a number of potential interventions avail-
able, which may be chemical (sclerotherapy and non-ther-
mal non-tumescent techniques), thermal (laser, radiofre-
quency ablation) or surgical (high ligation, stripping and 
phlebectomy).5-7 These treatments may be used as single 
treatments or may be combined. At present, international 
guidelines  recommend  endovenous  treatments  as  a  first 
choice for patients with varicose veins and more advanced 
CVD.8, 9
To date, it is still unclear how national reimbursement 
systems influence treatment of patients with CVD. In Bel-
gium, endovenous thermal ablation (EVTA), mainly laser 
and radiofrequency ablation, has been reimbursed since 
2012.10, 11 However, there is an important restriction in re-
imbursement: catheters or fibers used for EVTA are reim-
bursed only once in a lifetime.
In Belgium 99% of the population has access to a unique 
system of health care reimbursement,12 regardless of the 
type of hospital or institution, public, semi-public or pri-
vate. Hence the billing data available from the Belgian Na-
tional Institute for Health and Disability Insurance (NIH-
DI)13 make it possible to analyze the intervention rates and 
their relative proportion related to age, gender or social 
status, in a specific field of medicine, for instance varicose 
veins and CVD. It is also possible to know the type of in-
(Cite this article as: Guillaume GM, Meeus P, Dalcq V, van der Borght L, Vuylsteke ME, de Maeseneer MG. 
Influence of reimbursement policies on phlebological surgical practice in Belgium between 2007 and 2017. Int 
Angiol 2020;39:267-75. DOI: 10.23736/S0392-9590.20.04305-9)
Key words: Epidemiology; Surgery; Ablation techniques; Insurance, health, reimbursement.
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Statistical analysis
The data presented in this document are based on the en-
tire population. Therefore, descriptive statistics (mean, 
median), were used to illustrate the techniques applied for 
treatment of varicose veins in Belgium.
Whenever descriptive statistics highlighted potentially 
interesting differences between regions, techniques and 
periods, hypotheses derived from these observations were 
tested by performing several statistical analyses on the 
data. In general, analyses with a variable of geographical 
location were performed on standardized data.13 While the 
data for the entire population could be analyzed, data per 
insured was not available. Therefore, the rate of use of care 
was computed per district, as well as per age category, gen-
der and reimbursement type, and used for statistical test-
ing. To investigate whether or not there was a trend break 
between the period 2007-2017 and 2015-2017 (overall and 
by  region),  regression  coefficients were  compared  using 
a t-test that takes into account the standard error of each 
regression coefficient and the number of years used in the 
regression. Additionally, to investigate whether the geo-
graphical distribution differed between the beginning and 
end point of the measurements,  the coefficients of varia-
tion (i.e. the ratios of the standard deviation to the mean, 
expressed as a percentage, to measure relative variability) 
from 2007-2009 and 2015-2017 were compared using χ2 
test for an asymptotic distribution.17 These analyses were 
conducted based on the overall rate of interventions and 
for each technique used separately.
Secondly, to investigate whether technique, region, 
gender  or  preference  scheme  significantly  influenced 
differences in utilization rate in 2017, a 4-way ANOVA 
with technique (3 levels: phlebectomy, perforating veins 
surgery, high ligation and stripping), region (3 levels: 
Brussels, Flanders, Wallonia), gender (2 levels) and re-
imbursement system (2 levels) was used. For this analy-
sis the raw data (not standardized) were studied. Testing 
effects were based on the type III sum of squares as the 
data were unbalanced and the reported p-values were 
corrected for multiple testing using the Tukey-Kramer 
method.
Finally, to further investigate uni- and bilateral interven-
tions another 4-way ANOVA was used with type interven-
tion (2 levels: uni- and bilateral), region, gender and reim-
bursement system.
All statistical analysis were performed using SAS/EG 
9.4  and  Excel  2016  (Microsoft Office  Professional  Plus 
2016).
Statistical significance was accepted at P<0.05.
based on the hypothesis that only one of the selected codes 
is invoiced to the same patient on the same day, because 
the reimbursement rules stipulate a priori that they cannot 
be cumulated.
The research addressed a variety of techniques for vari-
cose veins and their rate of use based on age, gender, social 
security status and geographical origin during the period 
2007-2017. Belgium can be subdivided into 43 districts 
and globally into 3 main regions (Flanders, Wallonia and 
Brussels). The results comparing regions were standard-
ized by age group, gender, and social security status.13 The 
social security status of insured persons indicates whether 
they have a low income and are eligible for an enhanced 
reimbursement of health care (preferential system) or they 
have a normal reimbursement system. In 2016, 18.9% of 
the insured were covered by the preferential system (PS) 
of reimbursement.16
Table I.— Reimbursement codes of venous surgery in Belgium.
Codification
1619190-161921 All equipment used for complete single or 
bilateral
Endovenous treatment of varicose veins of the 
lower
Limbs with laser or radiofrequency during the 
treatment
238173-238184, 238210-238221, 238276-238280
Of the classification of the billing codes 
(nomenclature) (since 2014)
688996-689500 All equipment used for complete single or 
bilateral
Endovenous treatment of varicose veins of the 
lower
Limbs with laser or radiofrequency during the 
treatment
238173-238184, 238210-238221, 238276-238280
Of the classification of the billing codes 
(nomenclature) (2012-2014)
238070-238081 Ligation, fulguration or resection: one varicose 
vein
238092-238103 Ligation, fulguration or resection: two or three 
varicose veins
238114-238125 Ligation, fulguration or resection of more than 
three varicose veins
238136-238140 Total removal of the small saphenous vein
238151-238162 High ligation of the great saphenous vein
238195-238206 High ligation and total resection of one of the two 
saphenous veins
238210-238221 High ligation and stripping of the great and small 
saphenous vein
238232-238243 High ligation and ligation, fulguration or resection 
of varicose veins
238276-238280 Bilateral resection of the great or small 
saphenous vein
238291-238302 Total sub-aponeurotic ligation of the perforating 
veins of a lower limb
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day hospitalization in Brussels and Wallonia (87%) and 
94% in Flanders. Day hospitalization has been progressing 
for 10 years, having increased from 79 to 91% on average.
The global rate of use of care was 364 per 100,000 insured 
persons for those under the regular reimbursement system 
whereas it was 250 per 100,000 for insured persons with PS 
(P<0.001) (Figure 1). Additionally, there was a significant 
two-way interaction for gender and reimbursement type (PS) 
(P<0.001). Comparisons showed that there was a significant 
lower average rate of use of care between reimbursement 
system for women (P<0.001) but not for men (P=0.46). The 
two-way interaction for region and gender and region and 
reimbursement type was not significant (both p ≥ 0.05).
During the period from 2007 to 2017, we observed a slight 
increase in the rate of interventions (+ 0.83% per year). 
During the period, 2015 to 2017, however, the number of 
interventions diminished by 3.86% per year with no differ-
ences between regions (Figure 2). This difference in trends 
between periods was statistically significant (P<0.01).
Large geographical disparities were observed in the use 
of care: in 2017, it ranged from 172 to 549 per 100.000 
insured in the different districts (Figure 3).11 Interestingly, 
the  coefficient  of  variation  (39%,  over  the  period  2007-
2009) decreased significantly in more recent years (19%, 
for the years 2015-2017) (P<0.001) (Table II).
Results
Overall intervention rates
The main results of the study are summarized in Table II. 
For classic surgery (high ligation and stripping), EVTA, 
perforating vein surgery and phlebectomy the annual mean 
intervention rate was 343 per 100,000 insured individuals 
for 2017, giving 37,333 interventions per year (for a total 
population of 11.000.000 inhabitants). Not taking into ac-
count phlebectomies and other interventions for small var-
icose tributaries, the rate falls to 229 per 100,000 insured. 
The average expenses for varicose veins surgery exceeded 
10 million euro per year. The vast majority of the interven-
tions were carried out by surgeons (99%).
The mean age of the patients was 53.4 years (SD=13.8), 
53.2 years (SD=13,6) for women and 54.2 years (SD=13.9) 
for men. Seventy percent of the interventions were carried 
out within the range of 40 to 69 years, regardless of gender.
For 2017, 74.6% of these procedures were done for 
women (P<0.001). This female predominance was ob-
served for all age groups. This difference did not vary ac-
cording to geographical region.
Most varicose vein surgery was performed on an outpa-
tient basis (mainly day surgery) (91.5%). However, there 
were marked regional differences with a lower rate of one 
Table II.— Summary of main study results.
Varicose veins
Total
High ligation 
and stripping
Thermal 
ablation Phlebectomy
Perforator 
veins
Unilateral 
surgery
Bilateral 
surgery
General use of care
Average number of interventions per year 37,333 23,085 12,257 12,326 1922 15,231 7854
Standardized rate of interventions per 100,000 
insured
342.79 211.97 112.54 113.18 17.65 139.85 72.12
Average age (years) 53.43 53.17 52.73 53.6 55.48 53.39 52.73
Percentage women 74.63 69.69 71.96 84.27 72.01 67.70 73.55
Percentage of ambulatory interventions 91.46 89.37 90.46 95.61 90.01 91.29 85.64
Ratio of preferential regime to general regime 0.69 0.67 0.63 0.71 0.72 0.69 0.64
Trends
Trend (2007-2017): % increase (+) or decrease (-) 
per year
+0.83% +1.84% +7.69% -0.35% -2.11% +0.24% +6.04%
Trend (2015-2017): % increase (+) or decrease (-) 
per year
-3.86% -6.12% +3.60% +2.42% -11.49% -8.27% -1.46%
Statistically significant difference? P<0.01 P<0.001 P<0.01 P<0.01 P<0.001 P<0.001 P<0.001
Evolution of the coefficient of variation (by district)
Coefficient of variation (%) (2007-2009) 38.97 23.94 Na 90.93 162.88 28.65 38.4
Coefficient of variation (%) (2015-2017) 18.99 21.33 47.48 44.58 121.22 25.21 38.8
Statistically significant difference? P<0.001 NS Na P<0.001 NS NS NS
Expenses
Average annual expenses (€) €10,064 999 € 7103 584 € 1425 606 € 1023 870 € 511 939 € 3506 751 € 3596 833
Average cost of interventions (€) € 269.60 € 307.71 € 116.31 € 83.07 € 266.36 € 230.24 € 457.96
Main health care providers
Percentage surgeons 99.16 99.84 100.00 97.75 99.95 99.77 99.97
NS: not significant; NA: not applicable.
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tions on the saphenous trunks, representing 33% of all 
interventions.
Trends in utilization rates were quite different from one 
technique to another (Table II).
There was a significant decrease in high ligation/strip-
ping as well as in perforator ligation in 2015-2017 com-
pared to the whole decade (for both P<0.001). On the other 
hand, there was a significant increase in the use of phle-
bectomies (P<0.01). The use of EVTA techniques, which 
were not reimbursed before 2012, was increasing fast with 
a rate of 3.6% per year during 2015-2017.
Variations in techniques showed great disparities be-
tween regions: based on the intervention rate for 2017 the 
four-way ANOVA showed a significant main effect for re-
gion, (P=0.03). The average rate of use for high ligation 
and  stripping  was  significantly  higher  in Wallonia  than 
in in Flanders (P<0.001), whereas the rate of EVTA was 
lower in Wallonia than in Flanders (P<0.001). The average 
phlebectomy rate was significantly larger in Flanders than 
in Wallonia (P<0.001).
Unilateral versus bilateral interventions on saphenous 
trunks
A total of 7.854 bilateral interventions were carried out 
in 2017, representing 34% of all saphenectomy interven-
tions, regardless of the technique used (endovenous or sur-
gical). These procedures are performed less frequently in 
an ambulatory setting (only in 85%).
Variations according to techniques
Of all the surgical interventions for CVD, 62% con-
cerned surgical interventions on saphenous trunks, by 
stripping or endovenous techniques. Phlebectomies 
also represented one third of the procedures (33%), 
while perforator ligation was declared in 5% of cases. 
The proportion of minimally invasive, laser or radio-
frequency interventions, counted for 53% of interven-
Figure 1.—Comparison of intervention rate for chronic venous disease 
according to social security status by region (2017).
H.C. services: health care services (for varicose veins and more ad-
vanced chronic venous disease); TOTAL: the whole country Belgium; 
normal system: patients benefiting from the usual reimbursement; pref-
erential system: patients with a low income, benefiting from enhanced 
reimbursement of health care services.
Figure 2.—Evolution of intervention rate for chronic venous disease by 
region (2007-2017).
H.C. services: health care services (for varicose veins and more ad-
vanced chronic venous disease); TOTAL: the whole country Belgium.
Figure 3.—Geographical variations in surgical interventions for chron-
ic venous disease in Belgian districts (2017). The color scale indicates 
the coefficient of variation, which is expressed as a percentage: orange 
and red colors indicate districts with more use of care for chronic ve-
nous disease than the mean for Belgium, green colors those with less.11
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based on registered billing information. We looked at the 
global  use  of  care  and  the  influence  of  patient-related 
variations, such as age, gender, social status (based on the 
reimbursement system covering individual patients) and 
geographical origin. Globally, there was a large female 
preponderance, the underprivileged social classes used 
less care than expected and there was a remarkably large 
geographical disparity in care. Differences in the use of 
certain techniques like phlebectomies and the use of en-
dovenous procedures were mainly based on geographical 
location, being more frequently used in Flanders than in 
Wallonia.
Global use of care for varicose veins
In 2017, 343 patients per 100,000 insured underwent a 
treatment for varicose veins (C2-C6). This may seem quite 
high, if compared to data from the international literature, 
where such numbers are usually rather cited for more 
severe cases of CVD (C3-C6).18-21 It should be pointed 
out, however, that intervention rate falls to only 229 per 
100,000 if interventions for varicose tributaries are not in-
cluded.
A decreasing rate of interventions has been observed 
starting in 2015. The same evolution has also been de-
scribed in other European countries.22 The diminishing 
number of interventions cannot be accounted for by an ep-
idemiologic change. The underlying hypothesis is that the 
reduction seen is associated with the increased application 
of techniques which cannot be detected by looking at the 
existing codes  for  surgery:  for  instance,  it  is most  likely 
that ultrasound-guided foam sclerotherapy (UGFS), not 
included in the coding system yet, is gradually replacing 
surgical techniques for treating refluxing saphenous trunks 
in certain indications, conform international guidelines.8, 9
Despite recent stabilization of the use of care after an 
unexplained  period  of  sustained  growth  between  2009 
and 2011, the rate of use has remained particularly high in 
Flanders in comparison with both Wallonia and Brussels 
(Figure 2). One of the reasons may be that in Flanders the 
use of endovenous interventions is more established, than 
in the two other regions. Since the side-effects, especially 
pain after the procedure, are less pronounced after endo-
venous treatment, the threshold to be treated may be lower 
for patients in Flanders.
Patient related variations
Women are over-represented in the use of care for varicose 
veins, since they account for about three-quarters of inter-
ventions. This is even more pronounced for phlebectomy, 
Examining possible trends in the last decade, we found a 
slight divergence between unilateral and bilateral interven-
tions. Unilateral interventions were stable in the last decade 
(+0.24% / year) but decreased sharply in the last period 
(-13.18%/ year 2015-2017). The bilateral ones, which had 
been growing since 2007 (+6% per year), were decreasing 
slightly since 2015 (-1.46%) especially in Wallonia (-4.78% 
over 2015-2017). As a result, the percentage of bilateral 
procedures, which had been stable between 2007 and 2012 
(22%), increased sharply from 2012 onwards and then sta-
bilized at 33% in 2016 and 2017. Figure 4 shows the evolu-
tion of the bilateral surgical intervention rate per 100,000 
insured persons over the period 2007 to 2017 for the entire 
country as well as the variations recorded by region.
Based on the rate of use of interventions on saphenous 
trunks  for  2017  the  four-way ANOVA showed a  signifi-
cant main effect for the type of intervention (uni- versus 
bilateral), (P<0.001). The average rate of use of unilateral 
interventions was still significantly higher than that of bi-
lateral interventions (P<0.001).
There was also a significant effect for region, (P<0.001). 
Comparisons indicated that there was a significant differ-
ence in average rate of use of bilateral procedures between 
Flanders and Wallonia (P<0.001) and between Flanders 
and Brussels (P=0.001) (Figure 4). The average rate in 
Brussels and Wallonia did not differ significantly (P=0.36).
Discussion
This study analyzed the variation in utilization of several 
surgical techniques for treating varicose veins in Belgium, 
Figure 4.—Evolution of bilateral interventions rate for chronic venous 
disease by region (2007-2017).
H.C. services: health care services (for varicose veins and more ad-
vanced chronic venous disease); Total: the whole country Belgium.
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of phlebectomies can be questioned. Is it due to local surgi-
cal practice, to the replacement of this technique by UGFS 
or to differences in interpretation of the nomenclature?
Replacement of stripping by endovenous techniques
Surgical techniques to treat symptomatic saphenous in-
competence have been evolving over recent years and in-
ternational guidelines now recommend endovenous tech-
niques  as  the  first  treatment  choice.8, 9, 32-35 These mini-
mally invasive EVTA techniques have been reimbursed in 
Belgium since the end of 2012 and are used without differ-
ence for specific age groups, gender or type of reimburse-
ment system (usual or PS). The observed variability is es-
sentially related to the patient’s geographical location: the 
implementation of endovenous techniques does not seem 
to be as rapid in Wallonia as in Flanders. It can be hypoth-
esized that this will change over time, as these techniques 
become more established, also in the south of the country.
Along with the introduction of endovenous techniques, 
there has been a significant increase in bilateral interven-
tions, from 22% in 2007, which corresponds to general ep-
idemiological data, to 33% in 2017. This increase was sig-
nificantly more striking in Flanders than in Wallonia. The 
fact that endovenous equipment is eligible for reimburse-
ment only once in a patient’s lifetime in Belgium carries a 
risk of encouraging over-treatment, by excessive schedul-
ing of bilateral interventions from the outset, also in cases 
where only a unilateral treatment may have been needed. 
Offering treatment of the contralateral leg without proper 
indication is not supported by any international guideline.
Limitations of the study
Several possible biases and limitations should be high-
lighted, mainly directly linked to the Belgian coding and 
billing system.
First, sclerotherapy could not be analyzed in the pres-
ent study. Indeed, there is only one reimbursement code 
for sclerotherapy, which covers the various indications 
and techniques used, from micro-sclerotherapy for minor 
telangiectasia and reticular veins (C1) up to UGFS of sa-
phenous trunks. It is not possible to differentiate between 
indications  for  treatment  (clinical  and duplex ultrasound 
findings) based on the billing codes. Hence, we were not 
able to measure the use of UGFS, although this is nowa-
days an essential technique in the management of CVD. 
Invoicing practices probably vary from one clinician to 
another, and a code for sclerotherapy may be linked to a 
duplex ultrasound or  even  to  a  phlebectomy code. This, 
of course, is a wrong interpretation of the reimbursement 
where the rate rises to 85%. These figures are seen in every 
region in Belgium and for the different types of insured 
persons. Epidemiological studies show that venous dis-
ease is more common among women than men.23 In Bel-
gium the female/male ratio is at the upper end of the range 
seen internationally, where the ratio tends to be more about 
2 to 1. This raises the question of relative underuse of care 
by men, or relative overuse by women.
The median age at which patients undergo operations 
for varicose veins is 54 years, both for men and for women, 
for all techniques and across all regions. This result was 
expected in view of the natural history of CVD, which be-
comes worse with age, balanced against surgical risks.24-29
A third type of variability in practice is quite remark-
able: patients belonging to the most underprivileged social 
classes, covered by the PS, are clearly under-represented 
in all the categories studied. Access to care, including sur-
gery, endovenous techniques and phlebectomy is almost 
50% lower in this group. These differences are surprising 
in comparison with other studies on variability in practice 
in Belgium, where social status did not seem to influence 
the use of care.13 Moreover,  the  difference  is  significant 
only for women. It is therefore difficult to link this lower 
rate  to difficulties  in access  to care only. An explanation 
would be that, among these social classes, treatment for 
CVD is rather considered as an unnecessary luxury. This 
difference in use of care is regrettable since late treatment, 
at more severe stages of CVD, entails more risks of dete-
rioration in socio-professional and quality of life terms and 
also has adverse economic consequences.30
Finally, major geographical disparities are seen in the 
use of care for varicose veins. This variability appears to 
reveal large differences between treatment practice over 
the country. Obviously, these cannot be accounted for by 
epidemiology of CVD or by international recommenda-
tions. It is difficult to conclude whether these regional dif-
ferences are rather linked to specific surgical practices31 or 
to patients’ habits.
Choice of surgical procedure
Four types of surgical interventions were included: high 
ligation and stripping, endovenous techniques, phlebec-
tomy and surgical  ligation of perforating veins. The first 
three account for approximately equal shares. Ligation of 
perforating veins, which accounts for only 5% of interven-
tions, is only carried out in certain regions. Variability in 
practice appears to be mostly geographical rather than be-
ing linked to patient characteristics.
The high level of variability over the country in the use 
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rules, due to the absence of a proper coding for reimburse-
ment of UGFS and makes a proper evaluation of the im-
pact of UGFS in Belgium impossible.
Second, the rate of use for endovenous interventions may 
have been underestimated, related to the fact that reimburse-
ment of EVTA  techniques  is only  allowed  to be  certified 
once in a patient’s lifetime. If a patient needs to undergo a 
second operation using again an endovenous technique, the 
healthcare institution has to provide the catheter or fiber and 
equipment without any reimbursement and the intervention 
is usually coded as ‘classic’ surgery. Hence in the present 
study such cases were erroneously added to the wrong cat-
egory of treatment technique. We estimate, however, that 
the impact of such errors is not very significant, since re-
imbursement for the equipment in Belgium only began re-
cently and hence not so many patients will have undergone 
a second intervention already since the end of 2012.
Third, endovenous treatment of the small saphenous 
vein only is not eligible for reimbursement, unless the 
small saphenous vein is treated at the same time as the 
great saphenous vein. It is unknown if and how surgeons 
certify these interventions.
Fourth, the rate of use can be influenced by the number 
of procedures by patient during the same year (more pro-
cedures the same day, or more procedures during the same 
year). We have not studied whether there have been one 
or more interventions for a single patient in a single year, 
which may have slightly influenced the results.
Finally,  the  rate  of  use  can  be  influenced  by  the  sur-
geons’ habits or his/her workplace. In this study the geo-
graphical criteria are linked to the patient’s geographical 
origin and not the geographical location of the place of 
treatment. However, it is likely, but not certain, that most 
patients choose a health care institution close to their home 
for treatment of CVD.
Conclusions
In 2017, 343 patients per 100,000 insured underwent a 
treatment for varicose veins in Belgium, representing a 
stable situation over the last 10 years. Although there is 
access to health care for all inhabitants, there is a strik-
ingly lower use of care for varicose veins by individuals 
with a low income. Endovenous techniques have been 
implemented at a faster pace in the north than in the south 
of the country. There are remarkably more bilateral vari-
cose veins procedures than in surrounding countries. The 
wide geographical variations in treatment techniques may 
depend more on the surgeon’s habits or patients’ expecta-
tions than on international scientific guidelines.
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